Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
14
Number of overlapping holdings
11.9%
% of XBI's 119 holdings also in BBH
56.0%
% of BBH's 27 holdings also in XBI
Overlap by Weight
Sector Drift (XBI minus BBH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XBI |
Weight in BBH |
Overlap | |
|---|---|---|---|---|
 |
ALNYLAM PHARMACEUTICALS INC | 2.8% | 4.4% | 2.8% |
|
INSMED INC | 2.6% | 2.6% | 2.6% |
|
NATERA INC | 2.5% | 4.5% | 2.5% |
|
VERTEX PHARMACEUTICALS INC | 2.5% | 11.2% | 2.5% |
|
BIOGEN IDEC INC | 2.5% | 3.4% | 2.5% |
Position Highlights (Non-Overlapping Exposures)
XBI Overweight Relative to BBH
|
UNITED THERAPEUTICS CORP | 2.5% |
|
ABBVIE INC | 2.4% |
|
MADRIGAL PHARMACEUTICALS, INC. | 2.3% |
|
VAXCYTE, INC. | 2.1% |
|
BLUEPRINT MEDICINES CORP. | 2.0% |
|
EXELIXIS INC | 1.9% |
|
TG THERAPEUTICS INC | 1.7% |
|
HALOZYME THERAPEUTICS INC | 1.6% |
|
BRIDGEBIO PHARMA, INC. | 1.6% |
|
CYTOKINETICS INC | 1.5% |
XBI Underweight Relative to BBH
|
AMGEN INC | -13.6% |
|
GILEAD SCIENCES INC | -10.1% |
|
VERTEX PHARMACEUTICALS INC | -8.7% |
 |
ARGENX SE ADR | -5.1% |
|
IQVIA HOLDINGS INC | -4.4% |
 |
ICON PLC | -3.6% |
|
REGENERON PHARMACEUTICALS | -2.9% |
|
INTRA-CELLULAR THERAPIES INC | -2.9% |
|
ILLUMINA INC | -2.7% |
 |
BIONTECH SE SPONSORED ADR | -2.4% |